Literature DB >> 12031545

Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro.

Julian Goggi1, Ian A Pullar, Stephen L Carney, Henry F Bradford.   

Abstract

This study examined the influence of brain-derived neurotrophic factor (BDNF) on the basal and depolarisation-induced release of the neurotransmitters GABA, dopamine and serotonin from rat striatal brain slices in vitro. BDNF potentiated the potassium or veratrine-stimulated release of GABA, dopamine and serotonin. This potentiation was shown to be dependent on activation of the high-affinity tyrosine kinase-linked receptor TrkB, as K252a (a potent TrkB antagonist) largely prevented the effects. BDNF potentiated the release of each neurotransmitter to similar extents irrespective of the type of depolarising stimulus used. In all cases the potentiation of neurotransmitter release caused by BDNF was dependent on membrane depolarisation as BDNF alone was incapable of causing potentiation. These results, obtained using striatal slices in vitro, suggest that BDNF may be acting via the specific receptor TrkB to modulate synaptic performance in the corpus striatum in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12031545     DOI: 10.1016/s0006-8993(02)02505-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  31 in total

1.  Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.

Authors:  Wenzhen Duan; Qi Peng; Naoki Masuda; Eric Ford; Erik Tryggestad; Bruce Ladenheim; Ming Zhao; Jean Lud Cadet; John Wong; Christopher A Ross
Journal:  Neurobiol Dis       Date:  2008-03-10       Impact factor: 5.996

Review 2.  Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations.

Authors:  Mark P Mattson; Wenzhen Duan; Ruqian Wan; Zhihong Guo
Journal:  NeuroRx       Date:  2004-01

3.  Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Authors:  Kirill O Eremin; Vladimir S Kudrin; Pirjo Saransaari; Simo S Oja; Igor A Grivennikov; Nikolay F Myasoedov; Kirill S Rayevsky
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

4.  Valence-specific effects of BDNF Val66Met polymorphism on dopaminergic stress and reward processing in humans.

Authors:  Marta Peciña; Mercedes Martínez-Jauand; Tiffany Love; Joseph Heffernan; Pedro Montoya; Colin Hodgkinson; Christian S Stohler; David Goldman; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

5.  Aberrant striatal dopamine transmitter dynamics in brain-derived neurotrophic factor-deficient mice.

Authors:  Kelly E Bosse; Francis K Maina; Johnna A Birbeck; Marion M France; Joseph J P Roberts; Michelle L Colombo; Tiffany A Mathews
Journal:  J Neurochem       Date:  2011-12-02       Impact factor: 5.372

6.  Brain-derived neurotrophic factor enhances cholinergic contraction of longitudinal muscle of rabbit intestine via activation of phospholipase C.

Authors:  M Al-Qudah; C D Anderson; S Mahavadi; Z L Bradley; H I Akbarali; K S Murthy; J R Grider
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-19       Impact factor: 4.052

7.  Gender-dependent modulation of brain monoamines and anxiety-like behaviors in mice with genetic serotonin transporter and BDNF deficiencies.

Authors:  Renee F Ren-Patterson; Lauren W Cochran; Andrew Holmes; Klaus-Peter Lesch; Bai Lu; Dennis L Murphy
Journal:  Cell Mol Neurobiol       Date:  2006-09-22       Impact factor: 5.046

Review 8.  Prolonged fasting as a method of mood enhancement in chronic pain syndromes: a review of clinical evidence and mechanisms.

Authors:  Andreas Michalsen
Journal:  Curr Pain Headache Rep       Date:  2010-04

9.  Voltage-gated Na+ channel activation induces both action potentials in utricular hair cells and brain-derived neurotrophic factor release in the rat utricle during a restricted period of development.

Authors:  Christian Chabbert; Ilana Mechaly; Victor Sieso; Pierre Giraud; Aurore Brugeaud; Jacques Lehouelleur; François Couraud; Jean Valmier; Alain Sans
Journal:  J Physiol       Date:  2003-09-08       Impact factor: 5.182

10.  The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model.

Authors:  Qi Peng; Naoki Masuda; Mali Jiang; Qing Li; Ming Zhao; Christopher A Ross; Wenzhen Duan
Journal:  Exp Neurol       Date:  2007-11-09       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.